The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.

Completed

• Conditions: Hypothyroidism; Hyperthyroidism; Adrenal Insufficiency; Subacute Thyroiditis; COVID-19; Low Triiodothyronine Syndrome

• Registration Number: NCT05070091
• Lead Sponsor: Medical University of Gdansk

Brief Summary

The main focus of the study is the assessment of hormonal function in the course of COVID-19 infection with special regard for trends predicting clinical events defined as primary endpoints of the study.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-26
• Study First Submitted: 2021-10-04
• Study First Submitted QC: 2021-10-05
• Study First Posted: 2021-10-06
• Primary Completion: 2021-12-01
• Study Completion: 2021-12-01
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-07
• Last Update Posted: 2022-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

• PCR-confirmed COVID-19 infection
• volunteers consenting to participate

Exclusion Criteria

• no consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Meeting the primary endpoint criteria.	Time of hospitalization, typically less than one month.	Primary endpoint is defined as a composite endpoint including death, mechanical ventilation, vasopressor use, noninvasive ventilation, prolonged hospital stay (\>10 days).

Trial Locations

Locations (2)

Medical University of Gdansk; 🇵🇱 Gdańsk, Poland

7 Szpital Marynarki Wojennej; 🇵🇱 Gdańsk, Poland